Team:RAMNOTIREN CALGARY

From 2014hs.igem.org

(Difference between revisions)
 
(129 intermediate revisions not shown)
Line 1: Line 1:
<html>
<html>
 +
<head>
 +
<link rel='stylesheet' type='text/css' href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Stylesheets/indexcss.css?action=raw&ctype=text/css"/>
 +
 +
<style>
 +
h1{
 +
font-size: 1em;
 +
                        display: none;
 +
}
 +
 +
                #firstheading {
 +
                        display: none;
 +
                }
 +
 +
h3{
 +
font-size: 25.5px;
 +
}
 +
 +
p {
 +
text-indent:50px;
 +
}   
 +
 +
#box1 {
 +
width: 990px;
 +
margin-top: 8px;
 +
background: #E6E6E6; /*threedface*/
 +
float: left;
 +
padding-bottom: 20px;
 +
margin-bottom: 13px;
 +
position: relative;
 +
left: -60px;
 +
                     
 +
}
 +
 +
#box1 h3 {
 +
padding: 20px 0px 0px 10px;
 +
font-family: arial, verdana, "lucida sans";
 +
                        text-align: center;
 +
                       
 +
}
 +
 +
#box1 p {
 +
padding: 5px 30px 5px 30px;
 +
font-family: arial, verdana, "lucida sans";
 +
font-size: 15px;
 +
}
 +
 +
#content {
 +
z-index: 1;
 +
background-color: transparent;
 +
border: none;
 +
padding-bottom: 0;
 +
margin: 0;
 +
width: 100%;
 +
overflow: hidden;
 +
margin-top: -45px !important;
 +
height:auto !important; /* real browsers */
 +
height:100%; /* IE6: treaded as min-height*/
 +
min-height:100%; /* real browsers */
 +
}
 +
 +
#top-section {
 +
z-index: 2;
 +
height: 15px;
 +
margin: 0px;
 +
margin-left: auto;
 +
margin-right: auto;
 +
margin-bottom: 0 !important;
 +
padding:0;
 +
border: none;
 +
font-size: 10px;
 +
}
 +
 +
#p-logo {
 +
height:1px;
 +
overflow:hidden;
 +
display: none;
 +
}
 +
 +
#search-controls {
 +
overflow:hidden;
 +
display:block;
 +
background: none;
 +
position: absolute;
 +
top: 100px;
 +
right: 40px;
 +
}
 +
 +
.left-menu {
 +
width: 500px !important;
 +
display:block;
 +
margin-top:-80px;
 +
border: none;
 +
text-align: right;
 +
}
 +
 +
.left-menu ul {
 +
border: none;
 +
}
 +
 +
#menubar.right-menu {
 +
width:300px;
 +
display:block;
 +
float:left;
 +
margin-top:-80px;
 +
border: none;
 +
}
 +
 +
.right-menu ul {
 +
border: none;
 +
width: 300px;
 +
}
 +
 +
.visualClear {
 +
display: none;
 +
}
 +
 +
.firstHeading {
 +
display: block;
 +
}
 +
 +
 +
#search-controls {
 +
display:none;
 +
}
 +
 +
#siteSub {
 +
display: none;
 +
}
 +
 +
#contentSub {
 +
display: none;
 +
}
 +
 +
p:first-child {
 +
display: block;
 +
}
 +
 +
h1{
 +
border:none;
 +
width: 100%;
 +
clear: both;
 +
}
 +
 +
 +
.progress{
 +
display: none;
 +
}
 +
 +
#vidbutt{
 +
position: relative;
 +
top:0px;
 +
left:-60px;
 +
background-color: #e6e6e6;
 +
padding: 0px 15px 0px 15px;
 +
border-radius: 5px;
 +
}
 +
 +
#notebutt{
 +
position: relative;
 +
top: -300px;
 +
left: 286px;
 +
background-color: #e6e6e6;
 +
padding: 0px 15px 20px 15px;
 +
border-radius: 5px;
 +
}
 +
 +
 +
 +
        #tweets{
 +
      position: relative;
 +
top:-834px;
 +
left:642px;
 +
      width: 280px;   
 +
}
 +
      #countdown{
 +
      position: relative;
 +
top: -815px;
 +
left:642px;
 +
}
 +
 +
 +
 +
    #sponsorsbox{
 +
clear: both;
 +
position: relative;
 +
                top: -600px;
 +
                left: -70px;
 +
width: 1005px;
 +
margin: 4px 0px;
 +
background: #EEEEEE;
 +
                border-radius: 3px;
 +
}
 +
#sponsorsbox h4{
 +
padding: 20px 20px 0px 20px
 +
}
 +
#sponsorsbox p{
 +
padding: 0px 20px;
 +
}
 +
#sponsorsbox table{
 +
width: 950px;
 +
margin-left: auto;
 +
margin-right: auto;
 +
background: #EEEEEE;
 +
}
 +
#sponsorsbox td{
 +
padding: 15px 0px;
 +
width: 300px;
 +
}
 +
#sponsorsbox img{
 +
display: block;
 +
margin-right: auto;
 +
margin-left: auto;
 +
}
 +
 +
    #exp1{
 +
      position: relative;
 +
top:-310px;
 +
left:-58px;
 +
      background-color: #e6e6e6;
 +
      padding: 10px 10px 10px 10px;
 +
width: 308px;
 +
    }
 +
 +
    #exp2{
 +
      position: relative;
 +
top:-405px;
 +
left: 288px;
 +
      background-color: #e6e6e6;
 +
            padding: 10px 10px 10px 10px;
 +
width: 308px;
 +
    }
 +
</style>
 +
 +
<script type="text/javascript" src ="https://2014hs.igem.org/common/jquery-latest.min.js"></script>
 +
 +
<script type="text/javascript">
 +
    function slider() {
 +
        var $current = $('#slides IMG.current');
 +
 +
        if ( $current.length == 0 ) $current = $('#slides IMG:last');
 +
        var $next =  $current.next().length ? $current.next()
 +
            : $('#slides IMG:first');
 +
 +
          $current.addClass('previous');
 +
        $next.css({opacity: 0.0})
 +
            .addClass('current')
 +
            .animate({opacity: 1.0}, 2500, function() {
 +
                $current.removeClass('current previous');
 +
    });
 +
 +
    var $navicurrent = $('.progress li.current');
 +
    if($navicurrent.length ==0) $navicurrent = $('.progress li:last');
 +
    var $navinext = $navicurrent.next().length ? $navicurrent.next() : $('.progress li:first');
 +
    $navicurrent.addClass('previous');
 +
    $navicurrent.removeClass('current previous');
 +
    $navinext.addClass('current').animate({opacity: 1.0}, 2500, function() {
 +
            });
 +
 +
    $('.progress li').click(function(){
 +
       
 +
        var $ncurrent = $(this);
 +
            $('.progress li').removeClass('current').removeClass('previous');
 +
            $('#slides IMG').removeClass('current').removeClass('previous');
 +
            $ncurrent.addClass('current');
 +
            var ncurrentindex = $ncurrent.index();
 +
        if(  ncurrentindex=== 0) $current = $('#slides IMG:first');
 +
            if(  ncurrentindex=== 1) $current = $('#slides IMG:eq(1)');
 +
            if(  ncurrentindex=== 2) $current = $('#slides IMG:eq(2)');
 +
            if(  ncurrentindex=== 3) $current = $('#slides IMG:last');
 +
            $current.addClass('current');
 +
 +
    });
 +
 +
    }
 +
 +
    $(function() {
 +
        setInterval( "slider()", 5000 );
 +
    });
 +
 +
    /*js for twitter feed*/
 +
    !function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");
 +
 +
</script>
 +
 +
<script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.2/jquery.js"></script>
 +
 +
</head>
<body>
<body>
-
<ul>
+
<div id="globalWrapper"/>
-
<li><a href="#team">Team</a></li>
+
-
<li><a href="#news">Notebook</a></li>
+
-
<li><a href="#contact">Results/Conclusions</a></li>
+
-
<li><a href="#about">Safety</a></li>
+
-
<li><a href="#about">Attributions</a></li>
+
-
<li><a href="#about">Human Practices</a></li>
+
-
</ul>
+
 +
    <div id="main-content"/>
-
</body>
+
    <div id="topmenubar" class="topleft-menu"/>
-
</html>
+
    <ul>
 +
    <li><a href="https://igem.org/Team_List?year=2014&division=high_school" style='color:#014457; cursor:pointer' target="blank">teams</a></li>
 +
    <li class='selected'><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY">Page</a></li>
 +
<li class='new'><a href="https://2014hs.igem.org/wiki/index.php?title=Talk:Team:RAMNOTIREN_CALGARY&action=edit&redlink=1">Discussion</a></li>
 +
    <li><a href="https://2014hs.igem.org/wiki/index.php?title=Team:RAMNOTIREN_CALGARY&action=edit">View Source</a></li>
 +
    <li><a href="https://2014hs.igem.org/wiki/index.php?title=Team:RAMNOTIREN_CALGARY&action=history">History</a></li>
 +
    <li><a href="https://igem.org/Login">Log in</a></li>
 +
</ul>
 +
</div>
-
{|align="justify"
+
<header>
-
|You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing.
+
<div id="slides">
-
|[[Image:RAMNOTIREN_CALGARY_logo.png|200px|right|frame]]
+
    <img src="https://static.igem.org/mediawiki/2014hs/9/96/Banner1.jpg" width="968" height="272" alt="" class="current" />
-
|-
+
    <img  src="https://static.igem.org/mediawiki/2014hs/0/00/Dnabg.jpg" width="968" height="272" alt="" />
-
|
+
    <img src="https://static.igem.org/mediawiki/2014hs/9/96/Banner1.jpg" width="968" height="272" alt="" />
-
''Tell us more about your project. Give us background.  Use this as the abstract of your project. Be descriptive but concise (1-2 paragraphs)''
+
    <img  src="https://static.igem.org/mediawiki/2014hs/0/00/Dnabg.jpg" width="968" height="272" alt="" />
-
|[[Image:RAMNOTIREN_CALGARY_team.png|right|frame|Your team picture]]
+
</div>
-
|-
+
<ul class="progress">
-
|
+
    <li class="current"><a href="#n_0">1</a> </li>
-
|align="center"|[[Team:RAMNOTIREN_CALGARY | Team RAMNOTIREN_CALGARY]]
+
    <li><a href="#n_1">2</a> </li>
-
|}
+
    <li><a href="#n_2">3</a> </li>
 +
    <li><a href="#n_3">4</a> </li>
 +
</ul>
-
<!--- Team Information Link --->
+
<div>
 +
<ul id="menu">
 +
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY‎" id="homelink">Home</a></li>
-
===Team===
+
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Members" id="teamlink">Team</a>
-
Tell us about your team, your school!
+
<ul>
 +
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Members">Members</a></li>
 +
<li><a href="https://igem.org/Team.cgi?id=1295" target="_blank">Official Profile</a></li>
 +
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/AboutCMHS">About CMHS</a></li>
 +
</ul>
 +
</li>
 +
                                  <li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Project/Content" id="projectlink">Content</a>
 +
<ul>
 +
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Project/Content">Overview</a></li>
 +
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/HumanPractices">Human Practices</a></li>
 +
                                                <li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Project/Safety">Safety</a></li>
 +
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/References">References</a></li>
 +
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Attributions">Attributions</a></li>
 +
</ul>
 +
</li>
-
Every year approximately eight million people die of cancer, and an additional fourteen million are diagnosed with the disease. The World Heath Organization predicts that without immediate action these numbers will increase by eighty percent by the year 2030.
+
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Parts" id="partslink">Parts</a></li>
-
Cancer needs an abundant source of oxygenated blood to grow. To achieve this cancer cells release angiogenic factors that promote vascular growth. Without these factors, cancer is unable to survive.  Consequently, current treatments focus on inhibiting the angiogenic factors released by cancer cells. Drugs that target cancer cells specifically have also been successful treatment options. Our project aims to combine these two therapeutic approaches to create a synthetic biological machine that seeks out cancer cells and inhibits angiogenesis.
+
-
We plan to design a bacterium that in the presence of cancer cells secretes an anti-angiogenic factor.  This will inhibit the growth of the capillary system that is crucial for cancer cell survival.
+
-
===Notebook===
+
<li><a class="drop" href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Notebook" id="notebooklink">Notebook</a></li>
-
Show us how you spent your days.
+
 +
<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Protocols" id="protocollink">Protocols</a></li>
-
===Results/Conclusions===
+
<li><a href="https://2014hs.igem.org" target="_blank">iGEM</a></li>
-
What did you achieve over the course of your semester?
+
</ul>
 +
</div>
 +
</header>
 +
<div id="box1"> <!--align="justify"-->
 +
<h3>Choking Cancer</h3>
 +
<p>Every year approximately eight million people die of cancer, and an additional fourteen million are diagnosed with the disease. The World Heath Organization predicts that without immediate action these numbers will increase by eighty percent by the year 2030.</p><p>Cancer needs an abundant source of oxygenated blood to grow. To achieve this cancer cells release angiogenic factors that promote vascular growth. Without these factors, cancer is unable to survive.  Consequently, current treatments focus on targeting/inhibiting the angiogenic factors released by cancer cells. Targeted therapy has also been a successful treatment option.</p><p>Our project aims to combine these two therapeutic approaches to create a synthetic biological machine that seeks out cancer cells and inhibits angiogenesis. We plan to design a bacterium that in the presence of cancer cells secretes an anti-angiogenic factor.  This will inhibit the growth of the capillary system that is crucial for cancer cell survival.</p>
-
===Safety===
+
</div>
-
What safety precautions did your team take? Did you take a safety training course? Were you supervised at all times in the lab?
+
 +
<div id="button1">
 +
  <a href="http://www.youtube.com/watch?v=C_5Z31mUmtc"><img id="vidbutt" src="https://static.igem.org/mediawiki/2014hs/6/67/VideoButton.png" width="300px" height="300px"></a>
 +
</div>
-
===Attributions===
+
<div id="button2">
-
Who worked on what?
+
  <a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Notebook"><img id="notebutt" src="https://static.igem.org/mediawiki/2014hs/9/95/Notebook.png" width="300px" height="300px"></a>
 +
<div id="exp1">
 +
<p>Click here to see the introductory video we used to familiarize ouselves with what we would be researching. </p>
 +
</div>
-
===Human Practices===
+
<div id="exp2">
-
What impact does/will your project have on the public? 
+
<p>Here is a record of our. We also want to thank everybody who helped us along the way!</p>
 +
</div>
-
===Fun!===
+
  <div id="tweets">
-
What was your favorite team snack?? Have a picture of your team mascot?
+
    <a class="twitter-timeline"  href="https://twitter.com/CentraliGEM"  data-widget-id="475046068170674176">Tweets by @CentraliGEM</a>
 +
    <script>!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");</script>
 +
</div>
 +
<div id="countdown">
 +
<iframe src="http://free.timeanddate.com/countdown/i478w11x/n43/cf111/cm0/cu4/ct3/cs1/ca2/co1/cr2/ss0/cac000/cpc000/pc9542aa/tc9542aa/fs90/szw256/szh108/tatCountdown%20to%20iGEM%20Jamboree/tac000/tptTime%20since%20Event%20started%20in/tpc000/iso2014-06-26T00:00:00/bo2" frameborder="0" width="258" height="110"></iframe>
 +
</div>
-
<forum_subtle />
+
 
 +
<div id="sponsorsbox">
 +
  <h4>
 +
    Our Sponsors
 +
  </h4>
 +
  <table>
 +
    <tr>
 +
      <td><a href="http://www.albertatechfutures.ca" target="_blank"><img style="width: 284px;" src="https://static.igem.org/mediawiki/2014hs/7/7a/AlbertaInno.png"/></a></td>
 +
      <td><a href="http://www.albertatechfutures.ca/AcademicProgramsiCORE/geekStarter.aspx" target="_blank"><img style="width: 284px;" src="https://static.igem.org/mediawiki/2014hs/0/0d/GeekStarter.png"/></a></td>
 +
      <td><a href="http://schools.cbe.ab.ca/b823/default.html" target="_blank"><img style="width= 284px;" src="https://static.igem.org/mediawiki/2014hs/6/6a/Ram.png"/></a></td>
 +
    </tr>
 +
  </table>
 +
</div>
 +
 
 +
</body>
 +
</html>

Latest revision as of 04:02, 21 June 2014

Choking Cancer

Every year approximately eight million people die of cancer, and an additional fourteen million are diagnosed with the disease. The World Heath Organization predicts that without immediate action these numbers will increase by eighty percent by the year 2030.

Cancer needs an abundant source of oxygenated blood to grow. To achieve this cancer cells release angiogenic factors that promote vascular growth. Without these factors, cancer is unable to survive. Consequently, current treatments focus on targeting/inhibiting the angiogenic factors released by cancer cells. Targeted therapy has also been a successful treatment option.

Our project aims to combine these two therapeutic approaches to create a synthetic biological machine that seeks out cancer cells and inhibits angiogenesis. We plan to design a bacterium that in the presence of cancer cells secretes an anti-angiogenic factor. This will inhibit the growth of the capillary system that is crucial for cancer cell survival.

Click here to see the introductory video we used to familiarize ouselves with what we would be researching.

Here is a record of our. We also want to thank everybody who helped us along the way!

Our Sponsors

Retrieved from "http://2014hs.igem.org/Team:RAMNOTIREN_CALGARY"